Corbus Pharmaceuticals Holdings (CRBP) Change in Acquisitions & Divestments (2021 - 2025)

Corbus Pharmaceuticals Holdings' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $37.5 million for Q3 2025.

• In Q3 2025, Change in Acquisitions & Divestments rose 59.67% year-over-year to $37.5 million; the TTM figure through Sep 2025 stood at $148.5 million (up 179.01% YoY), while the FY2024 annual figure was $59.5 million, down 14.43% from the prior year.
• Change in Acquisitions & Divestments was $37.5 million for Q3 2025 at Corbus Pharmaceuticals Holdings, up from $35.4 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $55.7 million in Q1 2025 to a low of $6.9 million in Q4 2021.
• Historically, Change in Acquisitions & Divestments has averaged $23.8 million across 5 years, with a median of $19.1 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments sank 61.86% in 2023, then surged 627.33% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $6.9 million in 2021, then soared by 36.77% to $9.4 million in 2022, then soared by 46.18% to $13.7 million in 2023, then jumped by 45.59% to $20.0 million in 2024, then soared by 87.67% to $37.5 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $37.5 million (Q3 2025), $35.4 million (Q2 2025), and $55.7 million (Q1 2025), per Business Quant data.